# Carbohydrate Antigen 125-guided Therapy in Heart Failure

> **NCT02008110** · PHASE4 · COMPLETED · sponsor: **Fundación para la Investigación del Hospital Clínico de Valencia** · enrollment: 360 (actual)

## Conditions studied

- Heart Failure

## Interventions

- **DRUG:** CA125 guided strategy
- **DRUG:** CA125 guided strategy
- **DRUG:** CA125 guided strategy
- **OTHER:** CA125 guided strategy
- **DRUG:** Standard treatment strategy
- **DRUG:** CA125 guided strategy

## Key facts

- **NCT ID:** NCT02008110
- **Lead sponsor:** Fundación para la Investigación del Hospital Clínico de Valencia
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-12
- **Primary completion:** 2014-07
- **Final completion:** 2015-05
- **Target enrollment:** 360 (ACTUAL)
- **Last updated:** 2016-02-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02008110

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02008110, "Carbohydrate Antigen 125-guided Therapy in Heart Failure". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02008110. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*